Further to DrugAlert vol 1044, HPS Pharmacies wish to give notice that Sanofi-Aventis is deferring its discontinuation of Epilim® Crushable tablets as follows:
Epilim® Crushable Tablets
Sodium valproate 100mg
ARTG 15373
Epilim® Crushable tablets are now set to be deleted from the Australian market on 30th September 2027. The Therapeutic Goods Administration (TGA) is in consultation with subject matter experts and the sponsor to develop a management strategy.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sanofi-Aventis on 1800 818 806 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates